Li J, Dell’Aniello S, Ernst P, et al.

Title: REALITI-A study: real-world oral corticosteroid-sparing effect of mepolizumab in severe asthma.

Citation: J Allergy Clin Immunol Pract
2022;10:2646–2656.

Country: UK, Belgium, Canada, Germany, Italy, Spain, USA | Indication: Asthma

This is a GSK-supported study

http://tago.ca/35753668
Scan to access the publication or visit
http://tago.ca/35753668